NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/11/2019
Back to search
Official data from USPTO
GENEUITY CLINICAL RESEARCH SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/11/2019
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
06/13/2008
Registration date
09/15/2009
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2019
Last transaction
10/11/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/01/2007
First use in commerce
09/01/2007
Drawing code
3
Owner type
03
Owner location
Maryville, TN
Examiner
HABEEB,MYRIAH A
Law office
L50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the stylized words "Geneuity Clinical Research Services". To the right of the stylized words is an illustrated sequence of gradually scaling dots that form a spiral.
Holders and representatives
Holders
Molecular Pathology Laboratory Network, Inc.
Representatives
MOLECULAR PATHOLOGY LABORATORY NETWORK, INC.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific researchconducting clinical trials; Medical laboratories; Medical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/11/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/11/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/06/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
08/29/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/15/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/03/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/03/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/03/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/26/2014
E815
TEAS SECTION 8 & 15 RECEIVED
09/26/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
09/15/2009
PUBO
PUBLISHED FOR OPPOSITION
06/30/2009
NPUB
NOTICE OF PUBLICATION
06/10/2009
DOCK
ASSIGNED TO EXAMINER
05/29/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/22/2009
ALIE
ASSIGNED TO LIE
05/22/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2009
PETG
PETITION TO REVIVE-GRANTED
05/04/2009
PROA
TEAS PETITION TO REVIVE RECEIVED
05/04/2009
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
04/21/2009
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
04/21/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/22/2008
GNRT
NON-FINAL ACTION E-MAILED
09/22/2008
CNRT
NON-FINAL ACTION WRITTEN
09/22/2008
DOCK
ASSIGNED TO EXAMINER
09/21/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
06/18/2008
NWAP
NEW APPLICATION ENTERED
06/17/2008
Continuous trademark protection
Get notified about every new filing that threatens GENEUITY CLINICAL RESEARCH SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.